OK, perhaps you are thinking… so what, Paul? You can just stop eating food with chemical sweeteners in it. All right. Let's say we assume the whole world decides this second to stop eating this kind of food. What about all the people who are already victims of this obesity epidemic? What about Meg Kane? What should she do? Should she die without ever kissing her Mr. Right? Should she never get to curl into the arms of her true love? Or feel like a kid again? Should Meg Kane just disappear? Maybe you know people who are that cold and heartless. But I know many Meg Kanes. They are in my family and are my friends. Look around. I bet you know many Meg Kanes too. I want Meg Kane to lose weight, find her Prince Charming, and feel like a kid again. And I can tell you that nothing is going to change unless someone steps up to help Meg Kane with a way to lose weight. Over the next two weeks, you and I get a chance to do well by doing good by helping Meg Kanes everywhere lose weight. Yes, that's right, I'd like to share a stock recommendation with you today for a company that has proven it can actually help Meg Kane lose weight. You need to know that the company has been developing its medical device to help people lose weight for over eight years now. So they have had plenty of time to figure out if it really works. And eight years on, the answer is clear. It works. | Turns out that the people who got the device lost 25% of their excess weight. | On Dec. 3, 2013, the company announced the results of its biggest clinical trial testing the device. The clinical trial had a total of 239 people in it. You need to understand that approximately half of those people got the company's medical device implanted, while the other received a placebo. So the results of the study were released in December. Turns out that the people who got the device lost 25% of their excess weight. If we use the 203-pound obesity standard, Meg Kane would have lost 48 pounds! You have to understand that no other kind of obesity therapy even comes close to these results. The best weight loss drug on the market right now can help you lose only 9%. Just a couple more notes for you to show you how incredible these results are: 41% of people that got the device lost 25% of their excess weight, and as many as 54% of people lost 20%. But the most telling number is that 78% of the patients who got this medical device are choosing to keep it after 18 months. Why would anyone keep using something that doesn't work? They wouldn't, and that's the point. The company has a stock market value of about $130 million. The device they make is the size of a small watch, weighs about a pound and is implanted in the left chest area through a procedure that takes a couple hours. You go home the same day after the procedure is complete. It works by vagal blocking -- like a pacemaker for your heart. Just like a pacemaker sends a little signal to your heart to keep it ticking, this device sends little signals to the main nerve that controls our digestive system, the vagus nerve, to control your hunger. Now the company is waiting for FDA approval so that patients in the U.S. can use it. They're awaiting the input of obesity experts. I believe approval will be granted on June 17, 2014 -- less than two weeks from today. | My research shows that this company's study results are the best of any medical therapy for obesity. | My research shows that this company's study results are the best of any medical therapy for obesity. The safety of their device is rock solid too. That's why I believe that FDA is going to approve this device. When they do, you could see this company soar even higher, by as much as 400%. So 400%… 150%? I know these numbers may look a bit nuts to you. But in July 2013, a company called Stereotaxis went from $1.65 to $7.34, a gain of 348%, when the FDA approved its Vdrive system. And Cyberonics jumped from $18.39 to $38.40, a gain of 108%, after an FDA advisory committee voted to recommend its device for depression in June 2004. And again in November 2010, An FDA advisory committee voted to recommend its skin cancer-screening device for approval and Mela Sciences stock jumped from $2.53 to $5.85, a gain of 131%. But you should know that there's a major difference between the company I have in mind today and all these other ones. The market for this obesity device is bigger than that for any of these other companies. Projections show 50% of Americans are on track to be obese in the next 20 years -- and spending could by $213 billion by 2030 -- up 44% from 2012. This is why gains of 400% or 150% are not outrageous at all. I know I say this to you every time. But it's true. If I could, I would buy as much of this company as I could. But as you know, Agora Financial, The Daily Reckoning's parent company, prohibits me from owning stocks that I recommend. It's absolutely critical that you buy this company right now, before June 17, 2014. First, the stock is cheap right now and as June 17 nears, other investors are going to come and bid the stock up and you may miss out on getting it at a good price. Second if you don't own the stock before June 17, you are going to be locked out. You won't get the benefit of the stock going up by 150% or more. In other words, if you want to be able to get these big gains, you must act now. Click here now for the full details before it's too late. Regards, Paul Mampilly for The Daily Reckoning P.S. Before I give you the details of the trade, I want to remind you of Meg Kane. My motto is "Doing well by doing good." This week, you can unquestionably do well by doing good by helping a company that could make a big difference in our fight against the man-made epidemic of obesity… and could land Meg Kane her first kiss. Once you're ready, click here for the details. |
No comments:
Post a Comment
Keep a civil tongue.